Cybin Inc. (CYBN) is a Biotechnology: Pharmaceutical Preparations company listed on AMEX. There were no new wire items for CYBN in the last 30 days. The most recent was published Jan 5, 2026.

Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

Latest news

25 items

CYBN FAQ

7 questions
  • What does Cybin Inc. do?
    Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program...
  • What is the latest news on CYBN?
    Quantisnow has not tracked any new filings, ratings or press releases for CYBN in the last 30 days. The most recent wire item was published on January 5, 2026.
  • Where does CYBN stock trade?
    Cybin Inc. (CYBN) is listed on AMEX.
  • What sector and industry is CYBN in?
    Cybin Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • What are analysts saying about CYBN?
    Across the last 5 analyst actions on Cybin Inc., there were 0 upgrades and 1 downgrade. The most recent action was from Guggenheim: Buy with a $35.00 price target on 2025-03-13. Recent price targets range from $7.00 to $35.00.
  • What companies are similar to CYBN?
    Notable peers in the same industry include MRK (Merck & Company Inc.), LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S), ABT (Abbott Laboratories), JNJ (Johnson & Johnson). Compare CYBN side-by-side with any of them on Quantisnow.
  • How can I track CYBN on Quantisnow?
    Quantisnow aggregates Cybin Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CYBN to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change